Effect of rosiglitazone on restenosis after coronary stenting in patients with type 2 diabetes

Abstract
No abstract available
Funding Information
  • National Center for Research Resources
  • U.S. Public Health Service
  • National Institutes of Health
  • University of Texas Medical Branch at Galveston (M01 RR 00073)

This publication has 29 references indexed in Scilit: